Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation
In recent years, significant progress has been made in new therapeutic approaches to breast cancer, particularly in patients with HER2-positive and HER2-negative/hormone receptor-positive (HR+) breast cancer. In the case of HER2-positive tumours, these approaches have included, in particular, treatm...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2021-04-14
|
| In: |
Geburtshilfe und Frauenheilkunde
Year: 2021, Volume: 81, Issue: 04, Pages: 469-480 |
| ISSN: | 1438-8804 |
| DOI: | 10.1055/a-1397-7170 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1055/a-1397-7170 Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/a-1397-7170 
|
| Author Notes: | Michael P. Lux, Andreas Schneeweiss, Andreas D. Hartkopf, Volkmar Müller, Wolfgang Janni, Erik Belleville, Elmar Stickeler, Marc Thill, Peter A. Fasching, Hans-Christian Kolberg, Michael Untch, Nadia Harbeck, Achim Wöckel, Christoph Thomssen, Carla E. Schulmeyer, Manfred Welslau, Friedrich Overkamp, Florian Schütz, Diana Lüftner, Nina Ditsch |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1762853736 | ||
| 003 | DE-627 | ||
| 005 | 20231010113412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210714s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/a-1397-7170 |2 doi | |
| 035 | |a (DE-627)1762853736 | ||
| 035 | |a (DE-599)KXP1762853736 | ||
| 035 | |a (OCoLC)1341418440 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lux, Michael Patrick |d 1974- |e VerfasserIn |0 (DE-588)124900305 |0 (DE-627)367769638 |0 (DE-576)294558853 |4 aut | |
| 245 | 1 | 0 | |a Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients |b = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation |c Michael P. Lux, Andreas Schneeweiss, Andreas D. Hartkopf, Volkmar Müller, Wolfgang Janni, Erik Belleville, Elmar Stickeler, Marc Thill, Peter A. Fasching, Hans-Christian Kolberg, Michael Untch, Nadia Harbeck, Achim Wöckel, Christoph Thomssen, Carla E. Schulmeyer, Manfred Welslau, Friedrich Overkamp, Florian Schütz, Diana Lüftner, Nina Ditsch |
| 246 | 3 | 1 | |a Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation |
| 264 | 1 | |c 2021-04-14 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.07.2021 | ||
| 520 | |a In recent years, significant progress has been made in new therapeutic approaches to breast cancer, particularly in patients with HER2-positive and HER2-negative/hormone receptor-positive (HR+) breast cancer. In the case of HER2-positive tumours, these approaches have included, in particular, treatment with pertuzumab, T-DM1, neratinib and, soon, also tucatinib and trastuzumab deruxtecan (neither of which has yet been authorised in Europe). In patients with HER2−/HR+ breast cancer, CDK4/6 inhibitors and the PIK3CA inhibitor alpelisib are of particular importance. Further novel therapies, such as Akt kinase inhibitors and oral SERDs (selective estrogen receptor down regulators), are already being investigated in ongoing clinical trials. These therapeutic agents are not only being introduced into curative, (neo-)adjuvant therapeutic settings for HER2-positive tumours; a first favourable study on abemaciclib as an adjuvant therapy has now also been published. In patients with triple-negative breast cancer, after many years of negative study results with the Trop-2 antibody drug conjugate (ADC) sacituzumab govitecan, a randomised study has been published that may represent a significant therapeutic advance. This review describes the latest developments in breast cancer subsequent to the ESMO Congress 2020. | ||
| 540 | |q DE-3 |a Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International |f CC BY-NC-ND 4.0 |2 cc |u https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Hartkopf, Andreas |d 1979- |e VerfasserIn |0 (DE-588)139124101 |0 (DE-627)703216279 |0 (DE-576)309901596 |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Janni, Wolfgang |e VerfasserIn |0 (DE-588)135832640 |0 (DE-627)57224651X |0 (DE-576)300670370 |4 aut | |
| 700 | 1 | |a Belleville, Erik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stickeler, Elmar |d 1965- |e VerfasserIn |0 (DE-588)1110784147 |0 (DE-627)86516584X |0 (DE-576)475779843 |4 aut | |
| 700 | 1 | |a Thill, Marc |d 1969- |e VerfasserIn |0 (DE-588)120154129 |0 (DE-627)08048333X |0 (DE-576)292066694 |4 aut | |
| 700 | 1 | |a Fasching, Peter Andreas |d 1975- |e VerfasserIn |0 (DE-588)129068780 |0 (DE-627)388703040 |0 (DE-576)297477099 |4 aut | |
| 700 | 1 | |a Kolberg, Hans-Christian |e VerfasserIn |0 (DE-588)117156564X |0 (DE-627)1040638228 |0 (DE-576)513790683 |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |0 (DE-588)134268083 |0 (DE-627)566077914 |0 (DE-576)300413572 |4 aut | |
| 700 | 1 | |a Harbeck, Nadia |e VerfasserIn |0 (DE-588)113605633 |0 (DE-627)511270666 |0 (DE-576)172888581 |4 aut | |
| 700 | 1 | |a Wöckel, Achim |d 1975- |e VerfasserIn |0 (DE-588)124691307 |0 (DE-627)364365838 |0 (DE-576)294450718 |4 aut | |
| 700 | 1 | |a Thomssen, Christoph |e VerfasserIn |0 (DE-588)1207932027 |0 (DE-627)1694239217 |4 aut | |
| 700 | 1 | |a Schulmeyer, Carla |e VerfasserIn |0 (DE-588)1211190218 |0 (DE-627)1699024839 |4 aut | |
| 700 | 1 | |a Welslau, Manfred |e VerfasserIn |0 (DE-588)1209579111 |0 (DE-627)1697239897 |4 aut | |
| 700 | 1 | |a Overkamp, Friedrich |e VerfasserIn |0 (DE-588)1204138273 |0 (DE-627)1689266627 |4 aut | |
| 700 | 1 | |a Schütz, Florian |d 1972- |e VerfasserIn |0 (DE-588)12303387X |0 (DE-627)082307229 |0 (DE-576)293528810 |4 aut | |
| 700 | 1 | |a Lüftner, Diana |d 1967- |e VerfasserIn |0 (DE-588)128780738 |0 (DE-627)379681617 |0 (DE-576)297329499 |4 aut | |
| 700 | 1 | |a Ditsch, Nina |d 1974- |e VerfasserIn |0 (DE-588)124456944 |0 (DE-627)363361219 |0 (DE-576)187270244 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Geburtshilfe und Frauenheilkunde |d Stuttgart : Thieme, 1980 |g 81(2021), 04, Seite 469-480 |h Online-Ressource |w (DE-627)324451970 |w (DE-600)2026496-3 |w (DE-576)279447663 |x 1438-8804 |7 nnas |a Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation |
| 773 | 1 | 8 | |g volume:81 |g year:2021 |g number:04 |g pages:469-480 |g extent:12 |a Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation |
| 856 | 4 | 0 | |u https://doi.org/10.1055/a-1397-7170 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.thieme-connect.de/DOI/DOI?10.1055/a-1397-7170 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210714 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 12303387X |a Schütz, Florian |m 12303387X:Schütz, Florian |d 50000 |e 50000PS12303387X |k 0/50000/ |p 18 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1762853736 |e 3951035021 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1762853736","person":[{"role":"aut","family":"Lux","display":"Lux, Michael Patrick","given":"Michael Patrick"},{"given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut"},{"role":"aut","family":"Hartkopf","given":"Andreas","display":"Hartkopf, Andreas"},{"family":"Müller","role":"aut","display":"Müller, Volkmar","given":"Volkmar"},{"role":"aut","family":"Janni","given":"Wolfgang","display":"Janni, Wolfgang"},{"family":"Belleville","role":"aut","display":"Belleville, Erik","given":"Erik"},{"given":"Elmar","display":"Stickeler, Elmar","family":"Stickeler","role":"aut"},{"family":"Thill","role":"aut","given":"Marc","display":"Thill, Marc"},{"family":"Fasching","role":"aut","given":"Peter Andreas","display":"Fasching, Peter Andreas"},{"display":"Kolberg, Hans-Christian","given":"Hans-Christian","role":"aut","family":"Kolberg"},{"role":"aut","family":"Untch","display":"Untch, Michael","given":"Michael"},{"role":"aut","family":"Harbeck","display":"Harbeck, Nadia","given":"Nadia"},{"role":"aut","family":"Wöckel","display":"Wöckel, Achim","given":"Achim"},{"given":"Christoph","display":"Thomssen, Christoph","role":"aut","family":"Thomssen"},{"given":"Carla","display":"Schulmeyer, Carla","family":"Schulmeyer","role":"aut"},{"family":"Welslau","role":"aut","display":"Welslau, Manfred","given":"Manfred"},{"given":"Friedrich","display":"Overkamp, Friedrich","role":"aut","family":"Overkamp"},{"role":"aut","family":"Schütz","given":"Florian","display":"Schütz, Florian"},{"family":"Lüftner","role":"aut","display":"Lüftner, Diana","given":"Diana"},{"role":"aut","family":"Ditsch","given":"Nina","display":"Ditsch, Nina"}],"name":{"displayForm":["Michael P. Lux, Andreas Schneeweiss, Andreas D. Hartkopf, Volkmar Müller, Wolfgang Janni, Erik Belleville, Elmar Stickeler, Marc Thill, Peter A. Fasching, Hans-Christian Kolberg, Michael Untch, Nadia Harbeck, Achim Wöckel, Christoph Thomssen, Carla E. Schulmeyer, Manfred Welslau, Friedrich Overkamp, Florian Schütz, Diana Lüftner, Nina Ditsch"]},"relHost":[{"disp":"Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe TherapiesituationGeburtshilfe und Frauenheilkunde","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"GEBFRA"}],"language":["ger"],"part":{"extent":"12","pages":"469-480","issue":"04","text":"81(2021), 04, Seite 469-480","volume":"81","year":"2021"},"note":["Erscheint monatlich","Gesehen am 08.11.2024"],"pubHistory":["Nachgewiesen 40.1980 -"],"title":[{"title":"Geburtshilfe und Frauenheilkunde","title_sort":"Geburtshilfe und Frauenheilkunde"}],"id":{"issn":["1438-8804"],"eki":["324451970"],"doi":["10.1055/s-00000020"],"zdb":["2026496-3"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1980-","publisher":"Thieme","publisherPlace":"Stuttgart ; New York, NY","dateIssuedKey":"1980"}],"recId":"324451970"}],"origin":[{"dateIssuedDisp":"2021-04-14","dateIssuedKey":"2021"}],"title":[{"subtitle":" = Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation","title":"Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients","title_sort":"Update breast cancer 2020 part 5 - moving therapies from advanced to early breast cancer patients"}],"id":{"eki":["1762853736"],"doi":["10.1055/a-1397-7170"]},"physDesc":[{"extent":"12 S."}],"titleTranslated":[{"translated":"Update Mammakarzinom 2020 Teil 5 – Einführung von Substanzen aus der metastasierten Therapiesituation in die frühe Therapiesituation"}],"note":["Gesehen am 14.07.2021"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a LUXMICHAELUPDATEBREA2021 | ||